Clinical Trial Update: Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease [Phase 1]

View source ↗

Summary

A Phase 1 safety study of adult stem cell therapy for severe leg artery disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Disease
• Critical Limb Ischemia

Drugs mentioned

• Adult stem cell therapy

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Critical Limb Ischemia, Arterial Occlusive Disease | Phase 1 | Status: TERMINATED